These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14966297)

  • 1. Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells.
    Wang L; Hsu CL; Ni J; Wang PH; Yeh S; Keng P; Chang C
    Mol Cell Biol; 2004 Mar; 24(5):2202-13. PubMed ID: 14966297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARF represses androgen receptor transactivation in prostate cancer.
    Lu W; Xie Y; Ma Y; Matusik RJ; Chen Z
    Mol Endocrinol; 2013 Apr; 27(4):635-48. PubMed ID: 23449888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells.
    Wang X; Yeh S; Wu G; Hsu CL; Wang L; Chiang T; Yang Y; Guo Y; Chang C
    J Biol Chem; 2001 Nov; 276(44):40417-23. PubMed ID: 11509567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervillin associates with androgen receptor and modulates its transcriptional activity.
    Ting HJ; Yeh S; Nishimura K; Chang C
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):661-6. PubMed ID: 11792840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
    Suh JH; Shong M; Choi HS; Lee K
    Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.
    Kang HY; Huang KE; Chang SY; Ma WL; Lin WJ; Chang C
    J Biol Chem; 2002 Nov; 277(46):43749-56. PubMed ID: 12226080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
    J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
    Liu J; Youn H; Yang J; Du N; Liu J; Liu H; Li B
    Prostate; 2011 Sep; 71(12):1276-86. PubMed ID: 21308712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
    Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
    Hu YC; Yeh S; Yeh SD; Sampson ER; Huang J; Li P; Hsu CL; Ting HJ; Lin HK; Wang L; Kim E; Ni J; Chang C
    J Biol Chem; 2004 Aug; 279(32):33438-46. PubMed ID: 15166229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.
    Li L; Xie H; Liang L; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C
    Carcinogenesis; 2013 Feb; 34(2):257-67. PubMed ID: 23104178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.
    Mu X; Chang C
    Prostate; 2003 Oct; 57(2):129-33. PubMed ID: 12949936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.